The Hungarian pharmaceutical company Gedeon Richter Plc. has announced on the website of the Budapest Stock Exchange that it has submitted an offer and entered into negotiations to acquire certain assets from Mithra Pharmaceuticals SA. In the statement, Richter confirms that it has participated in the monetisation process of Mithra, which was publicly initiated by […]

The Hungarian pharmaceutical company Gedeon Richter Plc. has announced on the website of the Budapest Stock Exchange that it expanded its partnership with Mithra Pharmaceuticals SA with a binding Head of Terms (HoT) agreement for the development and commercialization of the first estetrolbased combined oral contraceptive (15 mg estetrol (E4) / 3 mg drospirenone) and […]

The Hungarian pharma company Gedeon Richter Plc. and Mithra Pharmaceuticals of Belgium have signed a binding supply agreement for the active pharmaceutical ingredient (API) for the combined oral contraceptive Estelle® and Donesta®, a novel product candidate for the treatment of post-menopausal symptoms. The agreement, announced on the website of the Budapest Stock Exchange, specifies that […]

Gedeon Richter Plc. and Mithra Pharmaceuticals have announced that they signed a license agreement for the commercialisation of Donesta®, a novel product candidate for the treatment of post-menopausal symptoms, according to a statement on the website of the Budapest Stock Exchange. The completion of the agreement follows the signing of the Binding Term Sheet by […]